Evonik, AMSilk collaborate to produce sustainable silk protein

Recently, Evonik reached an agreement with German biotechnology company AMSilk to jointly mass produce innovative sustainable silk proteins, which are suitable for a variety of applications including high-end fashion, automotive smart materials and medical devices.

Materials made of silk protein have both excellent performance and environmental protection benefits. Evonik is currently producing the material at its contract development and manufacturing (CDMO) precision fermentation production site in Slovakia.

Thomas Riermeier, head of Evonik's medical and health business line, said: "AMSilk takes sustainable development as its core business philosophy. This perfectly fits with Evonik's development goals. We are very pleased to cooperate with AMSilk to provide intelligent biotechnology silk for major industries around the world. materials.” He said that Evonik’s medical and health business line has more than 30 years of rich experience in fermentation technology, is a reliable partner for advanced food ingredients, pharmaceutical companies and other innovative companies, and is also the nutrition and consumer chemicals business unit of the group important parts of.

Klaus Kjeldal, Chief Production Officer of AMSilk GmbH, said: "As one of the powerful and well-known brands in the field of global silk protein manufacturing, Evonik is not only a perfect production partner, but also an excellent strategic partner. The cooperation with Evonik will help We continue to improve the production process, and at the same time continue to expand the production scale, even covering regions outside Europe." AMSilk is the world's first supplier of mass-produced smart biotechnology materials, with an excellent technology platform based on silk protein. The company's technology converts artificial proteins into silk formulations including fibers, hydrogels and silk powder, which are widely used in the textile, medical device and consumer goods industries.